Editorial: Characterising the functional heterogeneity of synovial macrophages

• by Anna B. Montgomery, Deborah R. Winter

• June 30, 2026

Biomarkers of treatment response in rheumatoid arthritis: from conventional markers to tissue immunophenotype

• by N.A. Batashkov, E.V. Gerasimova, D.A. Gerasimova, D.V. Svetlichnyy, E.S. Petryakina, D.I. Tychinin, S.M. Yudin, V.S. Yudin, A.A. Keskinov, V.P. Bogdanov, E.G. Zotkin, A.M. Lila, D.V. Tabakov, M. Woroncow, V.I. Skvortsova, P.Yu Volchkov

• July 17, 2026

PRP Linked to Better Outcomes in Advanced Knee OA

In a small open-label randomized trial, 2 platelet-rich plasma injections were associated with greater 6-month improvements in pain and function than corticosteroid injection or oral aceclofenac among patients awaiting knee arthroplasty.

• by Andrea Surnit

• June 22, 2026

• 6 min

Comparative Transcriptional Profiling of Key Macrophage and Fibroblast Subpopulations in Rheumatoid Arthritis–Associated Lung Disease

• by Tracy Tabib, Ogechukwu Ezenwa, Joshua Sciurba, Eleanor B. Valenzi, John Sembrat, Brittany Cody, Jishnu Das, Robert Lafyatis, Dana P. Ascherman

• July 8, 2026